remestemcel-l
Showing 1 - 5 of 5
Ulcerative Colitis Trial in Cleveland (Remestemcel-L, Placebo)
Recruiting
- Ulcerative Colitis
- Remestemcel-L
- Placebo
-
Cleveland, OhioCleveland Clinic
Apr 4, 2022
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) Trial (Remestemcel-L,
Available
- Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
- Remestemcel-L
- +2 more
- (no location specified)
Apr 12, 2022
Crohn Colitis Trial in Cleveland (Remestemcel-L, Placebo)
Recruiting
- Crohn Colitis
- Remestemcel-L
- Placebo
-
Cleveland, OhioCleveland Clinic
Apr 4, 2022
Grade B aGVHD, Grade C aGVHD, Grade D aGVHD Trial in United States (remestemcel-L)
Completed
- Grade B aGVHD
- +2 more
- remestemcel-L
-
Los Angeles, California
- +19 more
Feb 18, 2022
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19 Trial in New York (Remestemcel-L)
No longer available
- Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
- Remestemcel-L
-
New York, New YorkMount Sinai Hospital
Feb 17, 2021